Clinical Trials Logo

Clinical Trial Summary

To assess the bioequivalence of OPC-41061 OD tablets and OPC-41061 conventional tablets at 15 and 30 mg in healthy adult male subjects.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02994394
Study type Interventional
Source Otsuka Pharmaceutical Co., Ltd.
Contact
Status Completed
Phase Phase 1
Start date January 6, 2017
Completion date February 28, 2017

See also
  Status Clinical Trial Phase
Completed NCT02875080 - Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male Subjects Phase 1
Completed NCT04182958 - A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects Phase 1
Completed NCT03902574 - Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg Phase 1
Completed NCT04415645 - Absorption, Metabolism, Excretion, and Mass Balance Study of [14C]-VVZ-149 in Healthy Adult Male Subjects Phase 1
Completed NCT01423435 - Study to Compare Pharmacokinetic Profiles of TRK-100STP in Japanese, Chinese, and South Korean Non-elderly Healthy Adult Males Phase 1
Completed NCT01258699 - A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects Phase 1